BRC imports the 1st ever cannabis flower from Latin America

A shipment of medical marijuana from South America has arrived in the United States — and it's all right with the feds. Biopharmaceutical Research Company — a California-based marijuana research lab that is one of 33 DEA applicants to grow Schedule I research marijuana — received a shipment of marijuana grown by Uruguayan-based medical marijuana company Fotmer Life Sciences. The difficulties in obtaining high-quality, DEA-approved marijuana for medical research are well documented. But BRC CEO George Hodgin said he was granted federal permission to import this marijuana because it is for genetic, biological and chemical analysis, not for human research. BRC already has a DEA Schedule I analysis license, a separate credential from those given to research the drug's impact on humans. BRC previously received a similar shipment of medical marijuana from Europe, and Fotmer has shipped cannabis to Australia, but both companies say this is the first time South American weed has been imported into the U.S. with federal permission. Read more →